Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Diabetes Obes Metab. 2017 Jun 2;19(10):1468–1472. doi: 10.1111/dom.12950

Figure 1. Effects of MK-0812 on metabolic parameters.

Figure 1

Terminal FBG (A), GHb%, body weights (C), collective weight of adipose tissue depots (D), eWAT weight (E), and insulin (F). ***P < 0.0001 ob/ob mice versus ob/+ mice. δδP < 0.001 MK-0812-treated ob/+ and ob/ob mice versus respective non-treated controls.